Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators

1. A method for treating an inflammatory disease or condition in a subject in need thereof comprising administering a composition comprising a transport construct, wherein the transport construct comprises a transport peptide of the amino acid sequence RRPPR (SEQ ID NO: 1) that is linked to a cargo moiety comprising a peptide of amino acid sequence selected from the group consisting of SEQ ID NOS: 3-6.

2. The method of claim 1 , wherein the inflammatory disease or condition is uveitis, multiple sclerosis, neuromyelitis optica, traumatic brain injury or inflammatory bowel disease.

3. The method of claim 1 , wherein the composition is administered by at least one route selected from the group consisting of intravenous, oral, inhalational, rectal, vaginal, transdermal, intranasal, buccal, sublingual, parenteral, intrathecal, intragastrical, ophthalmic, pulmonary and topical.

4. The method of claim 1 , wherein the transport construct of the composition is selected from the group consisting of: SEQ ID NO:1-SEQ ID NO:3; SEQ ID NO:1-SEQ ID NO:4; SEQ ID NO:1-SEQ ID NO:5; SEQ ID NO:1-SEQ ID NO:6; SEQ ID NO:3-SEQ ID NO:1; SEQ ID NO:4-SEQ ID NO:1; SEQ ID NO:5-SEQ ID NO:1; and SEQ ID NO:6-SEQ ID NO:1.

5. The method of claim 2 , wherein the transport construct of the composition is selected from the group consisting of: SEQ ID NO:1-SEQ ID NO:3; SEQ ID NO:1-SEQ ID NO:4; SEQ ID NO:1-SEQ ID NO:5; SEQ ID NO:1-SEQ ID NO:6; SEQ ID NO:3-SEQ ID NO:1; SEQ ID NO:4-SEQ ID NO:1; SEQ ID NO:5-SEQ ID NO:1; and SEQ ID NO:6-SEQ ID NO:1.

6. The method of claim 3 , wherein the transport construct of the composition is selected from the group consisting of: SEQ ID NO:1-SEQ ID NO:3; SEQ ID NO:1-SEQ ID NO:4; SEQ ID NO:1-SEQ ID NO:5; SEQ ID NO:1-SEQ ID NO:6; SEQ ID NO:3-SEQ ID NO:1; SEQ ID NO:4-SEQ ID NO:1; SEQ ID NO:5-SEQ ID NO:1; and SEQ ID NO:6-SEQ ID NO:1.